Navigation Links
CHPA Lauds Vermont's Adoption of HB 522
Date:6/6/2013

WASHINGTON, June 6, 2013 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA) today applauded the Vermont legislature and Governor Peter Shumlin (D) for their passage of House Bill 522, a bill that offers a solution to reducing the domestic production of methamphetamine through reasonable and balanced approaches.  The new law makes Vermont the 27th state to adopt the pseudoephedrine (PSE) tracking system known as the National Precursor Log Exchange (NPLEx).

NPLEx is a proven tool that allows retailers to block any unlawful purchases of cold or allergy medicines containing PSE.  Much like a credit card transaction, retailers enter the information of anyone attempting to purchase this medicine into the NPLEx database by swiping their state-provided identification at the point of sale.  The database then immediately informs the retailer whether the purchase exceeds the legal purchase limits for PSE established by the Combat Methamphetamine Act of 2005.  While the vast majority of consumers purchase PSE legally, some criminals will attempt to illegally obtain large quantities of the drug in order to manufacture methamphetamine.  NPLEx empowers retailers to block these illegal purchases at the counter, before they can happen, giving communities and law enforcement a new tool in preventing the illegal diversion of these medications.

Prior to the establishment of NPLEx, retailers were required to log PSE purchases in handwritten log-books that police would spend hours combing through for any suspicious activity.  With the implementation of NPLEx, police now have instant access to any PSE purchasing activity directly from their police cruiser, eliminating hours of cumbersome investigative work.  Since its inception, NPLEx has blocked hundreds of thousands of sales across the country, and led to scores of arrests, convictions and meth busts.

"With Governor Peter Shumlin's signature on House Bill 522, Vermont joins the network of 26 other states already utilizing illegal sales blocking technology," said Carlos Gutierrez, senior director of state government affairs for the Consumer Healthcare Products Association.  "NPLEx technology represents an effective and balanced solution to illegal methamphetamine production in Vermont--one that punishes criminals while protecting the rights of law-abiding citizens who rely on cold and allergy medicines containing pseudoephedrine.  We commend the Vermont Legislature and Governor Shumlin for pursuing a common sense policy that targets criminals without burdening honest Vermonters."

CHPA is the 132-year-old trade association representing U.S. manufacturers and distributors of over-the-counter medicines and dietary supplements.

chpa.org


'/>"/>
SOURCE Consumer Healthcare Products Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. The Leukemia & Lymphoma Society Applauds FDAs Approval of Lenalidomide for Patients with Relapsed or Refractory Mantle Cell Lymphoma
2. CHPA Applauds Nevadas Adoption of Assembly Bill 39
3. BIOCOM Applauds Arena Pharmaceuticals Commitment to Innovation, Contributions to Southern California Life Science Community
4. Pew Applauds Introduction of Bipartisan Antimicrobial Data Collection Act
5. CHPA Applauds Governor Mike Pence and the Passage of SB 496
6. Lupus Foundation of Florida Applauds Support for Biosimilars Legislation
7. Medical Device Manufacturing Coalition Applauds Passage of Medical Device Tax Repeal Amendment
8. CHPA Applauds New Mexico Adoption Of House Bill 146
9. Frost & Sullivan Lauds IncellDx for Developing a Novel, Non-invasive Method for Cervical Cancer Testing
10. Frost & Sullivan Lauds U-Systems for Its Unique Technology and Strategic Excellence Paving the Way for Robust Growth
11. Frost & Sullivan Lauds MobileHelp for Its Outstanding Products and Performance in the North American Health Technology Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical , ... company with their  2017 New Product Innovation Award for ... extensive primary and secondary medical device market research by Frost ... its first-to-market OTC, drug-free pain relief product, the AVACEN 100, ... to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)... Texas , Oct. 11, 2017  True ... services, has amplified its effort during National Breast ... about hereditary cancer risks. ... of Clinical Oncology calculated that more than 10 ... have inherited mutations in BRCA1 or BRCA2 and have ...
(Date:10/5/2017)... , Oct. 5, 2017  In response ... of Oral and Maxillofacial Surgeons (AAOMS) released prescribing ... – to be used as a first-line therapy ... Recognizing the ... AAOMS White Paper "Opioid Prescribing: Acute and Postoperative ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/12/2017)... ... 12, 2017 , ... First Healthcare Compliance (FHC), an industry ... a range of technology and learning solutions at the 68th Annual American Healthcare ... be held October 14–18, 2017 at the Mandalay Bay Resort in Las Vegas, ...
(Date:10/12/2017)... CITY, Fla. (PRWEB) , ... October 12, 2017 , ... ... cold therapy products, announced today the introduction of an innovative new design of the ... multipurpose pad so you get maximum comfort while controlling your pain while using cold ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... has recently contributed a medical article to the newly revamped Cosmetic Town ... article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
Breaking Medicine News(10 mins):